Home
Versant Venture Capital VI, 10% Owner: Monte Rosa Therapeutics GLUE Sell · Filed 24/10/30
Trade details
- Type
- Insider sale
- Amount
- $869,303.4
- Shares · price
- 89,990 sh · $9.66 a share
- Held after
- 2,007,948 sh
- Trade date
- 24/10/28
- Filed
- 24/10/30
- Days to filing
- 2 days
Sold 4.3% of holdings
- Share of holding sold
- 4.3%
Monte Rosa Therapeutics trades, last 26 weeks
What else happened in Monte Rosa Therapeutics around then
Filed or reported within 30 days of the trade day · 24/09/28~24/11/27Versant Venture Capital VI's recent trades
- Versant Venture Capital VI
SellLenz Therapeutics
SellLenz Therapeutics
LENZ
$3.9M
83,066 sh
$3.9M
Filed 25/10/02
Traded 25/09/30
- Versant Venture Capital VI
SellLenz Therapeutics
SellLenz Therapeutics
LENZ
$2.7M
57,502 sh
$2.7M
Filed 25/10/02
Traded 25/09/30
- Versant Venture Capital VI
SellLenz Therapeutics
SellLenz Therapeutics
LENZ
$2.3M
49,701 sh
$2.3M
Filed 25/10/02
Traded 25/09/30
- Versant Venture Capital VI
SellLenz Therapeutics
SellLenz Therapeutics
LENZ
$1.6M
34,405 sh
$1.6M
Filed 25/10/02
Traded 25/09/30
- Versant Venture Capital VI
SellLenz Therapeutics
SellLenz Therapeutics
LENZ
$8,321
177 sh
$8,321
Filed 25/10/02
Traded 25/09/30
